Omnicell Proclaims XT Amplify

Multi-year Innovation Program Designed to Maximize Worth and Outcomes for XT Automated Dishing out System

FORT WORTH, Texas–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Firm”), a pacesetter in remodeling the pharmacy care supply mannequin, in the present day introduced XT Amplify, a multi-year innovation program that’s meant to maximise worth for hospitals, well being programs, and post-acute care services which have invested in Omnicell’s XT Automated Dishing out System whereas additionally looking for to drive enhanced scientific and operational outcomes on the factors of care and inside pharmacies.

“We acknowledge that a few of our prospects are navigating tough operational and financial environments. We imagine Omnicell is properly positioned to deal with these present challenges whereas adapting for the long run,” mentioned Randall Lipps, chairman, president, chief govt officer, and founding father of Omnicell. “We’re assured the XT Amplify program will ship steady innovation that addresses these evolving and sophisticated wants, whereas serving to prospects to maximise outcomes and the worth of Omnicell automated allotting programs at present in use across the globe.”

The options inside the multi-year XT Amplify program are meant to reinforce nursing effectivity, scale back medicine errors and waste, and, in the end, assist well being programs obtain the aspirational outcomes outlined within the industry-defined imaginative and prescient of the Autonomous Pharmacy. The primary set of options that will likely be obtainable in North America embrace:

XTExtend: This complete console swap is meant to supply a excessive degree of safety whereas enhancing the person expertise. Designed to be backward suitable, the console goals to strengthen interoperability inside the healthcare facility, whereas maximizing worth of present expertise.

MedChill: Meant to enhance the protection and safety of particular person, temperature-controlled drugs, this safe gadget for suitable refrigeration helps item-level stock visibility that’s designed to maximise expiration dates to cut back waste and stockouts on the factors of care and inside pharmacies.

SupplyXpert: This stock administration software program is designed to handle medical provides housed inside the XT Provide cupboard and open-shelf places, offering insights into stockout occasions, inventory worth, key efficiency indicators, and optimization suggestions. This could lengthen the advantages of present tools whereas serving to prospects handle the growing prices of medical provides.

ServerScale: The on-premises OmniCenter digital server answer is now obtainable in a subscription format, that’s meant to permit prospects to remain present with the newest working programs in an effort to make sure infrastructure readiness in the present day, whereas offering a basis for the evolving and increasing well being system.

CarePlus: Omnicell’s market-leading automation options at the moment are supported by skilled companies which might be designed to enhance answer adoption and supply data-driven efficiency optimization data that’s anticipated to reinforce nursing and pharmacy effectivity.

XT Amplify is meant to allow all healthcare services, no matter the place they’re of their adoption and utilization of Omnicell’s XT Automated Dishing out System, to resolve necessary challenges in the present day and into the long run.

“We acknowledge the worth of technology-driven medicine administration. However putting in a brand new infrastructure and the change administration that comes with that may be very difficult,” mentioned Jennifer Hillman, PharmD, govt director of Pharmacy at San Antonio-based College Well being. “XT Amplify supplies us a path to implement revolutionary new options whereas maximizing the worth of our present expertise investments.”

XT Amplify is designed to assist healthcare services as they advance towards the industry-defined imaginative and prescient of the Autonomous Pharmacy that seeks to exchange guide, error-prone actions with automated processes which might be meant to be safer and extra environment friendly. To study extra, go to omnicell.com/XTAmplify.

About Omnicell

Since 1992, Omnicell has been dedicated to remodeling pharmacy care by means of outcomes-centric innovation designed to optimize scientific and enterprise outcomes throughout all settings of care. Via a complete portfolio of robotics, sensible units, clever software program, and skilled companies, Omnicell options are serving to healthcare services worldwide to cut back prices, enhance labor effectivity, set up new income streams, improve provide chain management, assist compliance, and transfer nearer to the {industry} imaginative and prescient of the Autonomous Pharmacy. To study extra, go to omnicell.com.

Every so often, Omnicell could use the Firm’s investor relations web site and different on-line social media channels, together with its LinkedIn web page www.linkedin.com/firm/omnicell, and Fb web page www.fb.com/omnicellinc, to reveal materials personal data and adjust to its disclosure obligations beneath Regulation Truthful Disclosure (“Reg FD”).

OMNICELL and the Omnicell brand are registered emblems of Omnicell, Inc. or certainly one of its subsidiaries.

Ahead-Trying Statements

To the extent any statements contained on this press launch take care of data that’s not historic, these statements are “forward-looking statements” inside the that means of the Non-public Securities Litigation Reform Act of 1995. With out limiting the foregoing, statements together with the phrases “anticipate,” “intend,” “could,” “will,” “ought to,” “would,” “might,” “plan,” “potential,” “anticipate,” “imagine,” “forecast,” “steering,” “outlook,” “objectives,” “goal,” “estimate,” “search,” “predict,” “challenge,” and related expressions are meant to establish forward-looking statements. Ahead-looking statements are topic to the incidence of many occasions outdoors Omnicell’s management. Such statements embrace, however are usually not restricted to, Omnicell’s deliberate new services and products or creating enhancements to present services and products, together with XTExtend, MedChill, SupplyXpert), ServerScale, and CarePlus, and the associated aims and anticipated advantages (and any implied monetary influence), and statements about Omnicell’s technique, plans, aims, promise and goal, objectives, alternatives, and market or Firm outlook. Precise outcomes and different occasions could differ considerably from these contemplated by forward-looking statements as a result of quite a few elements that contain substantial identified and unknown dangers and uncertainties. These dangers and uncertainties embrace, amongst different issues, (i) unfavorable basic financial and market situations, together with the influence and length of inflationary pressures, (ii) Omnicell’s potential to benefit from development alternatives and develop and commercialize new options and improve present options, (iii) discount in demand within the capital tools market or discount within the demand for or adoption of our options, programs, or companies, (iv) delays in installations of our medicine administration options or our extra advanced medicine packaging programs, (v) dangers associated to Omnicell’s investments in new enterprise methods or initiatives, together with its transition to promoting extra services and products on a subscription foundation (vi) dangers associated to failing to take care of anticipated service ranges when offering our Superior Companies or retaining our Superior Companies prospects, (vii) Omnicell’s potential to satisfy the calls for of, or keep relationships with, its institutional, retail, and specialty pharmacy prospects, (viii) continued and elevated competitors from present and future opponents within the medicine administration automation options market and the medicine adherence options market, (ix) dangers introduced by authorities rules, legislative adjustments, fraud and anti-kickback statues, merchandise legal responsibility claims, the end result of authorized proceedings, and different authorized obligations associated to healthcare, privateness, knowledge safety, and data safety, together with any potential governmental investigations and enforcement actions, litigation, fines and penalties, publicity to indemnification obligations or different liabilities, and antagonistic publicity because of the beforehand disclosed ransomware incident, (x) any disruption in Omnicell’s data expertise programs and breaches of information safety or cyber-attacks on its programs or options, together with the beforehand disclosed ransomware incident and any potential antagonistic authorized, reputational, and monetary results that will consequence from it and/or extra cybersecurity incidents, in addition to the effectiveness of enterprise continuity plans throughout any future cybersecurity incidents, nations, (xi) Omnicell’s potential to recruit and retain expert and motivated personnel, (xii) Omnicell’s potential to guard its mental property, (xiii) dangers associated to the supply and sources of uncooked supplies and elements or value fluctuations, shortages, or interruptions of provide, (xiv) Omnicell’s dependence on a restricted variety of suppliers for sure elements, tools, and uncooked supplies, in addition to applied sciences supplied by third-party distributors, and (xv) different dangers and uncertainties additional described within the “Danger Components” part of Omnicell’s most up-to-date Annual Report on Kind 10-Okay, in addition to in Omnicell’s different experiences filed with or furnished to america Securities and Change Fee (“SEC”), obtainable at . Ahead-looking statements must be thought of in mild of those dangers and uncertainties. Traders and others are cautioned to not place undue reliance on forward-looking statements. All forward-looking statements contained on this press launch communicate solely as of the date of this press launch. Omnicell assumes no obligation to replace any such statements publicly, or to replace the explanations precise outcomes might differ materially from these expressed or implied in any forward-looking statements, whether or not because of modified circumstances, new data, future occasions, or in any other case, besides as required by legislation.

Contacts

Betsy Martinelli

Director, Company Advertising and marketing

betsy.martinelli@omnicell.com